cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inovio Pharmaceuticals Inc
128 own
89 watching
Current Price
$10.38
$-0.71
(-6.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
290.92M
52-Week High
52-Week High
14.75000
52-Week Low
52-Week Low
3.84000
Average Volume
Average Volume
0.71M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization290.92M
icon52-Week High14.75000
icon52-Week Low3.84000
iconAverage Volume0.71M
iconDividend Yield--
iconP/E Ratio--
What does the Inovio Pharmaceuticals Inc do?
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells; and SynCon product design is also intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. It has completed, current or planned clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, Ebola, Middle East Respiratory Syndrome, and Zika virus. The company's partners and collaborators include MedImmune, LLC, the Wistar Institute, University of Pennsylvania, Defense Advanced Research Projects Agency, GeneOne Life Science, Plumbline Life Sciences, ApolloBio Corporation, Drexel University, the National Institutes of Health, HIV Vaccines Trial Network, National Cancer Institute, and U.S. Military HIV Research Program. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Read More
How much money does Inovio Pharmaceuticals Inc make?
News & Events about Inovio Pharmaceuticals Inc.
PR Newswire
1 year ago
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference PR Newswire PLYMOUTH MEETING, Pa., May 5, 2023 PLYMOUTH MEETING, Pa., May 5, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology...
PR Newswire
1 year ago
INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023 INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023 PR Newswire PLYMOUTH MEETING, Pa., April 28, 2023 PLYMOUTH MEETING, Pa., April 28, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused...
Fool.com Headlines
1 year ago
The company will present an abstract for its Ebola vaccine booster this month.Shares of Inovio Pharmaceuticals (NASDAQ: INO) were up 20% early Thursday afternoon after the biotech company announced that it will present its abstract for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at the 33rd...
PR Newswire
1 year ago
INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo) at ECCMID 2023 INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo) at ECCMID 2023 PR Newswire PLYMOUTH MEETING...
PR Newswire
1 year ago
INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference PR Newswire PLYMOUTH MEETING, Pa., March 3, 2023 PLYMOUTH MEETING, Pa., March 3, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on...
Frequently Asked Questions
Frequently Asked Questions
What is Inovio Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Inovio Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Inovio Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Inovio Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inovio Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Inovio Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Inovio Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inovio Pharmaceuticals Inc?
plus_minus_icon
What percentage is Inovio Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inovio Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.38
$-0.71
(-6.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00